Endorphins in endotoxin-induced hyperglycemia in mice

Area of Science:

• Neuroendocrinology
• Metabolic Physiology
• Immunopharmacology

Background:

• Endogenous opiate systems modulate various physiological responses.
• Endotoxin challenge can trigger significant metabolic alterations, including hyperglycemia.
• The precise role of central opiate pathways in endotoxin-induced metabolic changes remains unclear.

Purpose of the Study:

• To investigate the involvement of endogenous opiate systems in the hyperglycemic response to endotoxin administration in mice.
• To determine if central or peripheral opiate receptor blockade affects endotoxin-induced hyperglycemia.
• To assess the impact of opiate tolerance on the metabolic response to endotoxin.

Main Methods:

• Mice were challenged with endotoxin (80 micrograms).
• Opiate antagonists (naloxone, naltrexone, methyl naltrexone) were administered to assess receptor blockade.
• Opiate tolerance was induced via morphine administration.
• Hyperglycemic responses were measured and compared between treatment groups.

Main Results:

• Administration of naloxone and naltrexone significantly attenuated endotoxin-induced hyperglycemia.
• Methyl naltrexone, a peripheral antagonist, had no significant effect on hyperglycemia.
• Mice tolerant to morphine exhibited a blunted hyperglycemic response to endotoxin.
• These findings implicate central opiate receptors in mediating the hyperglycemic response.

Conclusions:

• Central nervous system endorphinergic mechanisms are critically involved in the hyperglycemic response to endotoxin.
• Centrally acting opiate antagonists can modulate metabolic adaptation during endotoxin shock by blocking brain opiate receptors.
• These findings highlight a neuro-metabolic link between the opiate system and the host's response to bacterial challenge.